The WIRB-Copernicus Group’s (WCG) Clinical Services Division has partnered with Prudentia Group, a provider of drug safety and pharmacovigilance consulting services, to deliver a comprehensive solution aimed at enhancing the quality, safety and regulatory compliance of adverse event monitoring in drug development.  Through its subsidiary, Vigilare International, WCG provides drug safety and pharmacovigilance services including consulting and quality assurance, adverse event processing, ...